Table 2.
No Previous SARS-CoV-2 diagnosis or positive test |
Previous SARS- CoV-2 diagnosis or positive test with symptoms |
Previous SARS- CoV-2 diagnosis or positive test without symptoms |
|||
---|---|---|---|---|---|
N (%) | N (%) | N (%) | |||
Long Stay (> 100 days) | 14681 (73.2) | 8072 (63.8) | 5107 (94.8) | 1502 (74.5) | <0.01 |
Short Stay (≤ 100 days) | 5380 (26.8) | 4587 (36.2) | 278 (5.2) | 515 (25.5) | |
Sex | <0.01 | ||||
Male | 7973 (38.1) | 5156 (39.2) | 2038 (36.3) | 779 (36.5) | |
Female | 12938 (61.9) | 8001 (60.8) | 3579 (63.7) | 1358 (63.5) | |
Age Group (years) | 0.01 | ||||
<65 | 3874 (18.5) | 2494 (19.0) | 1027 (18.3) | 353 (16.5) | |
65-74 | 4891 (23.4) | 3037 (23.1) | 1379 (24.6) | 475 (22.2) | |
75-84 | 5918 (28.3) | 3719 (28.2) | 1602 (28.5) | 597 (27.9) | |
≥85 | 6235 (29.8) | 3913 (29.7) | 1609 (28.6) | 713 (33.4) | |
Race/Ethnicity | |||||
Black | 2551 (12.2) | 1533 (11.7) | 764 (13.6) | 254 (11.9) | <0.01 |
Hispanic | 980 (4.7) | 566 (4.3) | 298 (5.3) | 116 (5.4) | <0.01 |
Comorbidities | |||||
COPD | 5614 (27.1) | 3441 (26.5) | 1660 (29.7) | 513 (24.3) | <0.01 |
Dementia | 9232 (44.6) | 5336 (41.1) | 2870 (51.3) | 1026 (48.5) | <0.01 |
Coronary artery disease | 5385 (26.0) | 3366 (25.9) | 1532 (27.4) | 487 (23.0) | <0.01 |
Diabetes | 8124 (38.9) | 5054 (38.5) | 2313 (41.2) | 757 (35.4) | <0.01 |
Congestive heart failure | 4944 (23.9) | 3105 (23.9) | 1426 (25.5) | 413 (19.5) | <0.01 |
Chronic kidney disease | 5714 (27.6) | 3638 (28.0) | 1572 (28.1) | 504 (23.8) | <0.01 |
Hypertension | 16394 (79.3) | 10175 (78.4) | 4577 (81.8) | 1642 (77.7) | <0.01 |
Cognitive Function Scale | <0.01 | ||||
Cognitively Intact | 6009 (29.0) | 4152 (31.9) | 1301 (23.2) | 556 (26.3) | |
Mildly Impaired | 4961 (23.9) | 3094 (23.7) | 1352 (24.2) | 515 (24.4) | |
Moderately Impaired | 6811 (32.9) | 4034 (31.0) | 2035 (36.4) | 742 (35.2) | |
Severely Impaired | 2949 (14.2) | 1746 (13.4) | 905 (16.2) | 298 (14.1) | |
ADL score, mean (SD) | 19.2 (5.5) | 19.0 (5.5) | 19.7 (5.5) | 18.6 (5.8) | |
ADL dependency quartile | <0.01 | ||||
0-17 | 5521 (26.4) | 3567 (27.2) | 1330 (23.7) | 624 (29.3) | |
18-20 | 5935 (26.8) | 3769 (28.7) | 1273 (22.7) | 551 (25.8) | |
21-22 | 4457 (21.4) | 2692 (20.5) | 1301 (23.1) | 464 (21.7) | |
23-28 | 5306 (25.4) | 3099 (23.6) | 1711 (30.5) | 496 (23.2) |
Note: Includes all residents that received at least one dose of vaccine
Indicates chi-squared test p-value